Market Research Logo

Canada Pharmaceuticals and Healthcare Report Q2 2016

Canada Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Canada is a significant manufacturing base for pharmaceutical companies as well as a marketin its own right. Despite the expanding implementation of cost-containment reforms and rising uptake oflower value generic drugs, the effects of these trends will be mitigated by rising demand for andconsumption of high volumes of prescriptions, particularly high value personalised medicines.

Headline Expenditure Projections

Pharmaceuticals: CAD23.06bn (USD18.04bn) in 2015 to CAD23.52bn (USD17.42bn) in 2016; +2.0%in local currency terms and -3.4% in US dollar terms.

Healthcare: CAD217.54bn (USD170.13bn) in 2015 to CAD225.19bn (USD166.81bn) in 2016; +3.5% inlocal currency terms and -2.0% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Canada 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Canada 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Canada 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Canada 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Canada 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Canada 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Canada 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Canada 2014-2020)
Industry Risk Reward Index
Americas Risk/Reward Index
Canada Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Canada 2010-2015)
Table: Healthcare Personnel (Canada 2010-2015)
Table: Healthcare Activity (Canada 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Retail Sector
Company Profile
Apotex
GlaxoSmithKline
Merck
Novartis
Valeant
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Canada 1990-2025)
Table: Key Population Ratios (Canada 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Canada 1990-2025)
Table: Population By Age Group (Canada 1990-2025)
Table: Population By Age Group % (Canada 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report